NCT01069094.
Methods | Randomised controlled trial |
Participants | Premenopausal women with fibroids |
Interventions | Telapristone acetate (12.5 mg, 25 mg and 50 mg) vs Lupron depot vs placebo |
Outcomes | Assess the safety of Progenta when administered in premenopausal women with symptomatic leiomyomata |
Notes | Protocol NCT01069094 in clinicaltrials.gov of telapristone acetate vs Lupron depot vs placebo. No results in database nor in published literature. States trial was completed |